Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

The new device would give Dexcom a CGM that can be worn for as long as competitor Abbott’s Freestyle Libre 3 Plus sensor. COO Jake Leach said in a February earnings call that the company hopes ...

Of the hundreds of millions of people living with diabetes, most liv. Dexcom wants to make sure they have tools to manage it.

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

Beta Bionics recently brought its iLet bionic pancreas to market in 2023 and completed an IPO to become a publicly-traded ...

In this article, we are going to take a look at where DexCom ... Most of these devices are standard CGMs, with only a few being implanted sensors. 133 products are either approved or in the ...

At the conference, first-ever accuracy and performance data will be presented for Dexcom’s upcoming G7 15 Day system,1 ...

The latest trend in health and fitness tracking may sound familiar: wearing continuous glucose monitors (CGMs). Many people ...

DexCom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, today announced the launch of its first multi-region report, the "Dexcom State of Type 2 Report: Access and Attitudes Across ...

Over 13 weeks, adults with type 2 diabetes using an automated insulin delivery (AID) system had a 0.6-percentage point ...

AI-enhanced glucose monitoring provides predictive analytics and personalized insights for better blood sugar management.